FMS-like tyrosine kinase 3 ligand From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
FMS-like tyrosine kinase 3 ligand (FLT3L ) is an endogenous small molecule that functions as a cytokine and growth factor that increases the number of immune cells (lymphocytes (B cells and T cells)) by activating the hematopoietic progenitors. It acts by binding to and activating FLT3 (CD135) which is found on what (in mice) are called multipotent progenitor (MPP) and common lymphoid progenitor (CLP) cells. It also induces the mobilization of the hematopoietic progenitors and stem cells in vivo which may help the system to kill cancer cells.[1]
FLT3L is crucial for steady-state plasmacytoid dendritic cell (pDC) and classical dendritic cell (cDC) development.[1] [2] A lack of FLT3L results in low levels of dendritic cells.
Contents 1 FLT3L in parasite clearance 2 References 3 Further reading 4 External links FLT3L in parasite clearance [ edit] FLT3L and its receptor are involved in the mammalian immune response to malaria. In strains of plasmodium, FLT3L was shown to be released from mast cells and cause the expansion of dendritic cells, leading to the activation of CD8+ T cells. The same paper suggested that FLT3L release was caused by stimulation of mast cells with uric acid, produced from a precursor secreted by the plasmodium parasite. .[3]
References [ edit] ^ a b Shortman, Ken; Naik, Shalin H. (2006). "Steady-state and inflammatory dendritic-cell development". Nature Reviews Immunology . 7 (1): 19–30. doi:10.1038/nri1996. PMID 17170756. .mw-parser-output cite.citationfont-style:inherit.mw-parser-output qquotes:"""""""'""'".mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em^ Rahman, Adeeb H.; Aloman, Costica (2013). "Dendritic cells and liver fibrosis". Biochimica et Biophysica Acta . 1832 (7): 998–1004. doi:10.1016/j.bbadis.2013.01.005. PMC 3641166 . PMID 23313573. ^ Guermonprez, Pierre; Helft, Julie (2013). "Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection". Nature Medicine . 19 (1): 730–738. doi:10.1038/nm.3197. PMC 3914008 . PMID 23685841. Further reading [ edit] Robinson, S N; Chavez, J M; Pisarev, V M; Mosley, R L; Rosenthal, G J; Blonder, J M; Talmadge, J E (2003). "Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice". Bone Marrow Transplantation . 31 (5): 361–9. doi:10.1038/sj.bmt.1703816. PMID 12634727. External links [ edit] Growth factors
Fibroblast
FGF receptor ligands: FGF1/FGF2/FGF5 FGF3/FGF4/FGF6KGF FGF7/FGF10/FGF22 FGF8/FGF17/FGF18 FGF9/FGF16/FGF20FGF homologous factors: hormone-like:
EGF-like domain TGFβ pathway Insulin-like Platelet-derived Vascular endothelial VEGF-A VEGF-B VEGF-C VEGF-D PGF Other
Cell signaling: cytokines
By family
Chemokine
CCL CCL1 CCL2/MCP1 CCL3/MIP1α CCL4/MIP1β CCL5/RANTESCCL6 CCL7 CCL8 CCL9 CCL11 CCL12 CCL13 CCL14 CCL15 CCL16 CCL17 CCL18/PARC/DCCK1/AMAC1/MIP4CCL19 CCL20 CCL21 CCL22 CCL23 CCL24 CCL25 CCL26 CCL27 CCL28 CXCL CXCL1/KCCXCL2 CXCL3 CXCL4 CXCL5 CXCL6 CXCL7 CXCL8/IL8 CXCL9 CXCL10 CXCL11 CXCL12 CXCL13 CXCL14 CXCL15 CXCL16 CXCL17 CX3CL XCL
TNF TNFA LymphotoxinTNFSF4 TNFSF5/CD40LG TNFSF6 TNFSF7 TNFSF8 TNFSF9 TNFSF10 TNFSF11 TNFSF13 TNFSF13B EDA Interleukin
Type I (grouped by receptor subunit)
γ chain IL2/IL15 IL4/IL13IL7 IL9 IL21 β chain IL6 like/gp130 IL12 family/IL12RB1Other
Type II
IL10 family IL10/IL22IL19 IL20 IL24 IL26 Interferon type IIIInterferon
I IFNA1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA7 IFNA8 IFNA10 IFNA13 IFNA14 IFNA16 IFNA17 IFNA21 IFNB1 IFNK IFNW1 II
Ig superfamily IL1 family: IL1A/IL1F1IL1B/IL1F2 1Ra/IL1F3 IL1F5 IL1F6 IL1F7 IL1F8 IL1F9 IL1F10 33/IL1F11 18/IL1G IL17 family
Other HematopoieticKITLG Colony-stimulating factor SPP1 MIF
By function/ cell
Growth factor receptor modulators
Angiopoietin Agonists: Angiopoietin 1Angiopoietin 4 Antagonists: Angiopoietin 2Angiopoietin 3 Kinase inhibitors: AltiratinibCE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2)CNTF Agonists: AxokineCNTF Dapiclermin EGF (ErbB)
EGF(ErbB1/HER1) Agonists : AmphiregulinBetacellulin EGF (urogastrone) Epigen Epiregulin Heparin-binding EGF-like growth factor (HB-EGF) Murodermin Nepidermin Transforming growth factor alpha (TGFα) Kinase inhibitors: AfatinibAG-490 Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: CetuximabDepatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Antibodies: ErtumaxomabPertuzumab Trastuzumab Trastuzumab duocarmazine Trastuzumab emtansine Kinase inhibitors: AfatinibAG-490 Lapatinib Mubritinib Neratinib ErbB3/HER3 Agonists: Neuregulins (heregulins) (1, 2, 6 (neuroglycan C))Antibodies: DuligotumabPatritumab Seribantumab ErbB4/HER4 Agonists: BetacellulinEpigen Heparin-binding EGF-like growth factor (HB-EGF) Neuregulins (heregulins) (1, 2, 3, 4, 5 (tomoregulin, TMEFF))
FGF
FGFR1 Agonists: Ersofermin FGF (1, 2 (bFGF), 3, 4, 5, 6, 8, 10 (KGF2), 20)Repifermin Trafermin Velafermin FGFR2 Agonists: Ersofermin FGF (1, 2 (bFGF), 3, 4, 5, 6, 7 (KGF), 8, 9, 10 (KGF2), 17, 18, 22)Palifermin Repifermin Sprifermin Trafermin Antibodies: AprutumabAprutumab ixadotin FGFR3 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23)Sprifermin Trafermin Antibodies: Burosumab (against FGF23)FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19)Trafermin Unsorted
HGF (c-Met) Agonists : Hepatocyte growth factorPotentiators: Dihexa (PNB-0408)Kinase inhibitors: AltiratinibAM7 AMG-458 Amuvatinib BMS-777607 Cabozantinib Crizotinib Foretinib Golvatinib INCB28060 JNJ-38877605 K252a MK-2461 PF-04217903 PF-2341066 PHA-665752 SU-11274 Tivantinib Volitinib Antibodies: EmibetuzumabFiclatuzumab Flanvotumab Onartuzumab Rilotumumab Telisotuzumab Telisotuzumab vedotin IGF
IGF-1 Agonists : des(1-3)IGF-1Insulin-like growth factor-1 (somatomedin C) IGF-1 LR3 Insulin-like growth factor-2 (somatomedin A) Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab (against IGF-1 and IGF-2)IGF-2 Agonists : Insulin-like growth factor-2 (somatomedin A)Antibodies: Dusigitumab Xentuzumab (against IGF-1 and IGF-2)Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7)Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)Trofinetide
LNGF (p75NTR ) Agonists: BDNFBNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540Dexamethasone EVT-901 (SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110)ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004Decoy receptors: LEVI-04 (p75NTR -Fc)PDGF Agonists: Becaplermin Platelet-derived growth factor (A, B, C, D)Kinase inhibitors: AgerafenibAxitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Sunitinib Sorafenib Toceranib Antibodies: OlaratumabRamucirumab Tovetumab RET (GFL)
GFRα1 Agonists: Glial cell line-derived neurotrophic factor (GDNF)Liatermin Kinase inhibitors: VandetanibGFRα2 Agonists: Neurturin (NRTN)Kinase inhibitors: VandetanibGFRα3 Kinase inhibitors: VandetanibGFRα4 Agonists: Persephin (PSPN)Kinase inhibitors: VandetanibUnsorted Kinase inhibitors: Agerafenib
SCF (c-Kit) Agonists: AncestimStem cell factor Kinase inhibitors: AgerafenibAxitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib Toceranib TGFβ Trk
TrkA Agonists: AmitriptylineBNN-20 BNN-27 Cenegermin DHEA DHEA-S Gambogic amide NGF Tavilermide Antagonists: ALE-0540Dexamethasone FX007 Testosterone Negative allosteric modulators: VM-902AKinase inhibitors: AltiratinibAZD-6918 CE-245677 CH-7057288 DS-6051 Entrectinib GZ-389988 K252a Larotrectinib Lestaurtinib Milciclib ONO-4474 ONO-5390556 PLX-7486 Rebastinib SNA-120 (pegylated K252a))Antibodies: Against TrkA: GBR-900; Against NGF: ABT-110 (PG110)ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004Decoy receptors: ReN-1820 (TrkAd5)TrkB Agonists: 3,7-DHF3,7,8,2'-THF 4'-DMA-7,8-DHF 7,3'-DHF 7,8-DHF 7,8,2'-THF 7,8,3'-THF Amitriptyline BDNF BNN-20 Deoxygedunin Deprenyl Diosmetin DMAQ-B1 HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 TDP6 Antagonists: ANA-12Cyclotraxin B Gossypetin (3,5,7,8,3',4'-HHF) Kinase inhibitors: AltiratinibAZD-6918 CE-245677 CH-7057288 DS-6051 Entrectinib GZ-389988 K252a Larotrectinib Lestaurtinib ONO-4474 ONO-5390556 PLX-7486 TrkC Kinase inhibitors: AltiratinibAZD-6918 CE-245677 CH-7057288 DS-6051 Entrectinib GZ-389988 K252a Larotrectinib Lestaurtinib ONO-4474 ONO-5390556 PLX-7486
VEGF Agonists: Placental growth factor (PGF)Telbermin VEGF (A, B, C, D (FIGF))Allosteric modulators: Cyclotraxin BKinase inhibitors: AgerafenibAltiratinib Axitinib Cabozantinib Cediranib Lapatinib Lenvatinib Motesanib Nintedanib Pazopanib Pegaptanib Rebastinib Regorafenib Semaxanib Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegolBevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: AfliberceptOthers Additional growth factors: Adrenomedullin Colony-stimulating factors (see here instead)Connective tissue growth factor (CTGF) Ephrins (A1, A2, A3, A4, A5, B1, B2, B3) Erythropoietin (see here instead)Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF) Glia maturation factor (GMF) Hepatoma-derived growth factor (HDGF) Interleukins/T-cell growth factors (see here instead)Leukemia inhibitory factor (LIF) Macrophage-stimulating protein (MSP; HLP, HGFLP) Midkine (NEGF2) Migration-stimulating factor (MSF; PRG4) Oncomodulin Pituitary adenylate cyclase-activating peptide (PACAP) Pleiotrophin Renalase Thrombopoietin (see here instead)Wnt signaling proteins Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)See also Receptor/signaling modulators Signaling peptide/protein receptor modulators Cytokine receptor modulators
Cytokine receptor modulators
Chemokine CSF
Erythropoietin Agonists: ARA-290Asialo erythropoietin Carbamylated erythropoietin CNTO-530 Darbepoetin alfa Epoetin alfa Epoetin beta Epoetin delta Epoetin epsilon Epoetin gamma Epoetin kappa Epoetin omega Epoetin theta Epoetin zeta Erythropoietin (EPO) Erythropoietin-Fc Methoxy polyethylene glycol-epoetin beta (CERA/Mircera) Peginesatide Pegol sihematide (EPO-018B) G-CSF (CSF3) Agonists: FilgrastimGranulocyte colony-stimulating factor Lenograstim Leridistim Lipegfilgrastim Nartograstim Pegfilgrastim Pegnartograstim GM-CSF (CSF2) Agonists: EcogramostimGranulocyte macrophage colony-stimulating factor Milodistim Molgramostim Regramostim Sargramostim Antibodies: MavrilimumabMOR103 Namilumab M-CSF (CSF1) Agonists: CilmostimInterleukin-34 Lanimostim Macrophage colony-stimulating factor Mirimostim Kinase inhibitors: AgerafenibSCF (c-Kit) Thrombopoietin Agonists: EltrombopagPegacaristim Promegapoietin Romiplostim Thrombopoietin (THPO, MGDF)
Interferon
IFNAR (α/β, I) Agonists: AlbinterferonInterferon alpha (interferon alfa, IFN-α) Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)Interferon alfa 2a Interferon alfa 2b Interferon alfa n1 Interferon alfacon-1 Interferon alpha-n3 Interferon beta (IFN-β) (IFNB1, IFNB3)Interferon beta 1a Interferon beta 1b Interferon kappa (IFN-ε/κ/τ/ζ, IFNK) Interferon omega (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: AnifrolumabFaralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: BifarceptIFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)Interferon gamma 1b Antibodies: EmapalumabFontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead.
Interleukin TGFβ TNF Others
JAK(inhibitors)
JAK1 Baricitinib Filgotinib Momelotinib Oclacitinib Ruxolitinib Tofacitinib (tasocitinib, CP-690550) Upadacitinib JAK2 AG-490 Atiprimod AZD-1480 Baricitinib CHZ868 Cucurbitacin I (elatericin B, JSI-124) CYT387 Lestaurtinib NSC-7908 NSC-33994 Pacritinib Ruxolitinib SD-1008 Tofacitinib (tasocitinib, CP-690550) JAK3 AG-490 Cercosporamide TCS-21311 Tofacitinib (tasocitinib, CP-690550) WHI-P 154 ZM-39923 ZM-449829
Others Additional cytokines: Cardiotrophin 1 (CT-1)FMS-like tyrosine kinase 3 ligand (FLT3L) Leukemia/leukocyte inhibitory factor (LIF) Oncostatin M (OSM) Thymic stromal lymphopoietin (TSLP) Additional cytokine receptor modulators: EmfilerminLestaurtinib Midostaurin Quizartinib Sorafenib Sunitinib
See also Receptor/signaling modulators Signaling peptide/protein receptor modulators Growth factor receptor modulators
Categories:
Cytokines Growth factors Biochemistry stubs Hidden categories:
Articles lacking in-text citations from March 2011 All articles lacking in-text citations All stub articles
Navigation menu Personal tools Not logged in Talk Contributions Create account Log in
Navigation Main page Contents Featured content Current events Random article Donate to Wikipedia Wikipedia store Interaction Help About Wikipedia Community portal Recent changes Contact page Tools What links here Related changes Upload file Special pages Permanent link Page information Wikidata item Cite this page Print/export Create a book Download as PDF Printable version (window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.416","walltime":"0.492","ppvisitednodes":"value":1358,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":263255,"limit":2097152,"templateargumentsize":"value":374,"limit":2097152,"expansiondepth":"value":12,"limit":40,"expensivefunctioncount":"value":3,"limit":500,"unstrip-depth":"value":1,"limit":20,"unstrip-size":"value":11311,"limit":5000000,"entityaccesscount":"value":2,"limit":400,"timingprofile":["100.00% 275.479 1 -total"," 40.82% 112.437 1 Template:Reflist"," 40.73% 112.207 20 Template:Navbox"," 39.21% 108.004 4 Template:Cite_journal"," 23.12% 63.695 1 Template:More_footnotes"," 13.45% 37.059 1 Template:Ambox"," 8.34% 22.982 1 Template:Cytokines"," 8.05% 22.183 1 Template:Growth_factor_receptor_modulators"," 5.87% 16.173 1 Template:Growth_factors"," 5.83% 16.065 1 Template:Cytokine_receptor_modulators"],"scribunto":"limitreport-timeusage":"value":"0.156","limit":"10.000","limitreport-memusage":"value":3963795,"limit":52428800,"cachereport":"origin":"mw2276","timestamp":"20181010130640","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":86,"wgHostname":"mw1270"););